Navigation Links
NovaScan decides against tax credits

Milwaukee, Wis. - NovaScan, an early-stage medical imaging company developing what it believes to be a novel tool for early detection of breast cancer, had to bypass angel tax credits from the State of Wisconsin to finance clinical trials for its emerging technology.

The company instead has raised a total of $385,000 from a combination of five......

Full article >>> otype imaging device that might be able to distinguish between the electrical properties of healthy tissue and malignant tissue. By identifying the electrical properties of different tissues, including healthy and malignant, the company might be able to promote earlier detection of different cancers.

NovaScan has targeted breast cancer as its initial application, and it might eliminate o......

Full article >>>
'"/>

Source:wistechnology.com By Joe Vanden Plas 08/15/06


Related biology technology :

1. State pledges $50K to NovaScan, Platypus
2. NovaScan qualifies for investor tax credits
3. Protector RNase Inhibitor Enhance the Protection of RNA against Degradation
4. Protecting your business against online brand abuse
5. Journalist warns against late arrival to the tech party
6. Wisconsin companies on the front lines in the war against cancer
7. Guarding against patent enforcement
8. Third Wave files patent suits against Digene, Chiron and Bayer
9. Third Wave sued by one firm; gets injunction against another
10. Third Wave wins patent lawsuit against California firm
11. Wisconsin Supreme Court rules against Microsoft
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/16/2017)... -- ImMAGE Biotherapeutics (OTCMKTS: IMMG), an early-stage biotechnology company harnessing the ... for triple negative breast cancer (TNBC), announced today their completion ... program. The YEi Start in France ... grow their business in France and ... to complete an intensive one week immersion in ...
(Date:2/16/2017)... 2017   Capricor Therapeutics, Inc. (NASDAQ: ... developing first-in-class biological therapies for cardiac and other ... to terminate its license agreement with the Mayo ... Cenderitide. "Our decision to return these ... our efforts to advance our core cell and ...
(Date:2/16/2017)... 2017  Champions Oncology, Inc. (NASDAQ: CSBR ... of advanced technology solutions and products to personalize the ... addition of new cohorts of PDX models to their ... expand Champions, product line in hepatocellular cancer, breast cancer, ... and non-small cell lung cancer (including EGFR mutation; ALK/ROS1 ...
(Date:2/16/2017)... , ... February 16, 2017 ... ... Molecular Research Inc. has further extended its industry leading Biochemistry Services specifically ... offers state-of-the-art cGMP techniques and methods for the biochemical and biosimilar ...
Breaking Biology Technology:
(Date:2/2/2017)... Feb. 1, 2017  Central to its deep ... advances worldwide, The Japan Prize Foundation today announced ... have pushed the envelope in their respective fields ... Three scientists are being recognized with the 2017 ... not only contribute to the advancement of science ...
(Date:1/31/2017)... , Jan. 31, 2017  Spero Therapeutics, LLC, ... for the treatment of bacterial infections, today announced ... antibacterial candidates from Pro Bono Bio Ltd (PBB) ... of multi-drug resistant forms of Gram-negative bacteria.   The ... Infectives Ltd, a PBB group company. ...
(Date:1/26/2017)...  Crossmatch, a leading provider of security and identity ... combatting fraud, waste and abuse in assistance operations around ... on Disaster Relief conference in Panama City ... and foreign assistance organizations throughout Latin America ... a largely unacknowledged problem in the foreign assistance and ...
Breaking Biology News(10 mins):